Spatio-temporal analyses in vitro revealed that perturbation of signaling pathways relevant for the initiation and maintenance of a migration front phenotype (e.g. the EGF/EGFR pathway) only partly reduced tumor cell motility (Fig. 3a). The gene discussed is EGF; the disease is neoplasm.